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Abstract The putative gene (ygcM) of Escherichia coli was
veri¢ed in vitro to encode the ortholog of 6-pyruvoyltetrahy-
dropterin synthase (PTPS). Unexpectedly, the enzyme was
found to convert sepiapterin to 7,8-dihydropterin without any
cofactors. The enzymatic product 7,8-dihydropterin was identi-
¢ed by HPLC and mass spectrometry analyses, suggesting a
novel activity of the enzyme to cleave the C6 side chain of
sepiapterin. The optimal activity occurred at pH 6.5^7.0. The
reaction rate increased up to 3.2-fold at 60^80‡C, re£ecting the
thermal stability of the enzyme. The reaction required no metal
ion and was activated slightly by low concentrations (1^5 mM)
of EDTA. The apparent Km value for sepiapterin was deter-
mined as 0.92 mM and the Vmax value was 151.3 nmol/min/
mg. The new catalytic function of E. coli PTPS does not imply
any physiological role, because sepiapterin is not an endogenous
substrate of the organism. The same activity, however, was also
detected in a PTPS ortholog of Synechocystis sp. PCC 6803
but not signi¢cant in Drosophila and human enzymes, suggest-
ing that the activity may be prevalent in bacterial PTPS
orthologs. 7 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
6-Pyruvoyltetrahydropterin synthase (PTPS, EC 4.6.1.10) is
an essential enzyme catalyzing the second step of tetrahydro-
biopterin (BH4) biosynthesis [1^3]. BH4 is a well-known co-
factor for aromatic amino acid hydroxylation and nitric oxide
synthesis in higher animals [4]. The de novo synthesis of BH4
starts from GTP by GTP cyclohydrolase I (GTPCH, EC
3.5.4.16), yielding dihydroneopterin triphosphate (H2-NTP).
H2-NTP is converted to 6-pyruvoyltetrahydropterin (PPH4)
by PTPS and then to BH4 by sepiapterin reductase (SR, EC
1.1.1.153). In addition, aldose reductase (EC 1.1.1.21) cata-
lyzes the reduction of the C2P-oxo group in PPH4 to yield
6-lactoyltetrahydropterin (LPH4) [5^7]. LPH4 is reduced fur-
ther to BH4 by SR or is oxidized non-enzymatically to sepia-
pterin. In the salvage pathway of BH4, sepiapterin is con-
verted to 7,8-dihydrobiopterin by SR and then to BH4 by
dihydrofolate reductase.
BH4 is ubiquitous in eukaryotes including fungi but not in
prokaryotes. There has been no report of BH4 synthesis in
prokaryotes, except for some bacteria, such as cyanobacteria
and Chlorobium sp., which produce glycosidic forms of BH4
[8^10]. BH4 synthesis in these organisms seems to follow the
same biochemical steps established in higher animals, being
catalyzed by the consecutive actions of GTPCH, PTPS, and
SR [11]. Even in the other prokaryotes, which do not synthe-
size BH4, GTPCH is essential for the synthesis of tetrahydro-
folate, whereas the other biosynthetic enzymes do not appear
to be required. Nevertheless, the gene encoding PTPS was
identi¢ed in the genome sequenced cyanobacterium Synecho-
cystis sp. PCC 6803, which produces 6-hydroxymethylpterin
glycoside [12]. Since 6-hydroxymethylpterin is an intermediate
in tetrahydrofolate synthesis, PTPS was not expected to be
present in this organism. However, a putative open reading
frame (ORF) slr0078 was veri¢ed to encode PTPS and to be
expressed under normal growth conditions [13], while no gene
encoding SR has been identi¢ed. Subsequent sequencing of
the genomes of several prokaryotes including Escherichia
coli has also revealed genes putatively encoding PTPS ortho-
logs. As these prokaryotes were not known to produce BH4,
it was doubted whether the PTPS orthologs have any physio-
logical function in the absence of SR. In order to answer this
question, we investigated the putative function of the PTPS
orthologs using E. coli as a model organism.
In this study, we cloned and overexpressed the putative
E. coli gene (ygcM) of the PTPS ortholog to identify the
enzymatic activity to synthesize PPH4 from H2-NTP. In order
to investigate a putative metabolic function of the enzyme
we intended to create E. coli transformants overproducing
PPH4 and BH4 individually by coexpression of E. coli
PTPS with GTPCH or GTPCH/SR. Synechocystis sp. PCC
6803 GTPCH and mouse SR were employed in the experi-
ment simply because their ORF clones were available and also
identi¢ed to produce functional proteins [13,14]. In the course
of analyzing the transformants, we found that E. coli PTPS
has a novel activity of bleaching the yellow color of sepiapter-
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in, giving rise to 7,8-dihydropterin. As the activity was so far
unknown in our knowledge in any enzymes, we characterized
the enzymatic properties and here report the results.
2. Materials and methods
2.1. Construction of plasmids
The putative E. coli PTPS gene (ygcM) was ampli¢ed by PCR from
genomic DNA using a primer pair, CATATGATGTCCACCACGT-
TAT (forward) and GGATCCTAACATAGCGTTACTTAA (re-
verse) containing restriction sites (underlined) for NdeI and BamHI,
respectively. The DNA was cloned into the pGEM-T vector (Prom-
ega) and subsequently cloned as an NdeI/BamHI restriction fragment
into pET-28a (pET-ePTPS). The overexpression plasmids of Synecho-
cystis sp. PCC 6803 GTPCH (pET-cGTPCH), Synechocystis sp. PCC
6803 PTPS (pET-cPTPS), mouse SR (pET-mSR), Drosophila PTPS
(pET-dPTPS), and human PTPS (pET-hPTPS) were prepared previ-
ously [13^16]. In order to coexpress E. coli PTPS and Synechocystis
sp. PCC 6803 GTPCH, a BglII/HindIII fragment of pET-cGTPCH
was introduced into the BamHI/HindIII site of pET-ePTPS plasmid,
giving rise to pET-cGTPCH/ePTPS. The plasmid pET-cGTPCH/
ePTPS was digested with BamHI/HindIII and then ligated with the
BglII/HindIII fragment of pET-mSR to generate pET-cGTPCH/
ePTPS/mSR plasmid. The plasmids were transformed into E. coli
BL21(DE3) (Novagen). DNA sequences were con¢rmed by sequenc-
ing.
2.2. Expression and puri¢cation of recombinant proteins
The transformed cell was grown at 37‡C in LB+Amp broth with
vigorous shaking. Overexpression was induced by 50 WM IPTG when
A600 reached 0.6. The cells were allowed to continue to grow over-
night and harvested by centrifugation. The cells were washed and
resuspended in lysis bu¡er (50 mM sodium phosphate, pH 8.0, 300
mM NaCl, 10 mM imidazole), and disrupted by sonication. The crude
extract obtained after centrifugation was applied to a column of Ni-
NTA gel (Qiagen) and puri¢ed by following the instructions in the
product manual. His-tag protein was eluted with 100 mM EDTA in
the lysis bu¡er. The puri¢ed protein was dialyzed against 10 mM
PIPES (pH 7.5) neutralized by NaOH, mixed with glycerol to a ¢nal
concentration of 10%, and stored at 370‡C until use.
2.3. Activity assay
PTPS activity to catalyze the synthesis of PPH4 from H2-NTP was
assayed in the absence or presence of SR [17,18]. The reaction mixture
consisted of 100 mM Tris^HCl (pH 7.5), 0.1 mM H2-NTP, 10 mM
MgCl2, 10 mM dithiothreitol, and aliquots of enzyme in a ¢nal vol-
ume of 50 Wl. In a coupled assay with SR, the mixture was supple-
mented with 0.2 mM NADPH and 5 Wg of recombinant mouse SR.
The mixture was incubated for 1 h at 37‡C and mixed with an equal
volume of an acidic iodine solution (2% KI and 1% I2 in 1 N HCl) for
1 h in the dark. After centrifugation, the supernatant was reduced
with ascorbic acid and subjected to HPLC. H2-NTP was prepared
from GTP by incubation with recombinant Synechocystis sp. PCC
6803 GTPCH [13] according to the published method [19].
The activity to convert sepiapterin to 7,8-dihydropterin was mea-
sured by disappearance of the yellow color at 420 nm. Unless stated
otherwise, all reactions were performed in the following conditions
(standard assay conditions). The reaction mixture contained 50 mM
PIPES, pH 7.5, 2.88 mM sepiapterin, and enzyme (17 Wg for E. coli
PTPS) in a total volume of 50 Wl. The reaction was performed at 37‡C
for 20 min; linearity of the reaction was observed up to 60 min. An
equal volume of cold 10% trichloroacetic acid was added to stop the
reaction and, after 10 min on ice, the mixture was centrifuged at
10 000Ug for 10 min. The supernatant was diluted 10-fold with water
and measured for remaining sepiapterin. In order to normalize the
quenching e¡ect of trichloroacetic acid on spectral absorption of se-
piapterin at 420 nm, every assay was accompanied by a blank reaction
without enzyme, especially when using di¡erent quantities of sepia-
pterin for kinetic analysis. The concentration of sepiapterin was cal-
culated from the molar extinction coe⁄cient, 10.4 mM31 cm31 at 420
nm [20].
2.4. HPLC analysis of pteridines
HPLC was performed on a Kontron Model 430 equipped with a
Rheodyne loop of 20 Wl, an Inertsil ODS-3 C18 column (5 Wm,
150U2.3 mm, GL Science, Japan), and a HP Model 1046A £uores-
cence detector (350/450 nm, excitation/emission). Pteridines were
eluted isocratically with 10 mM sodium phosphate (pH 6.0) at a
£ow rate of 1.2 ml min31 and monitored at 350/450 nm (excitation/
emission) as described previously [21]. Pteridine compounds were pur-
chased from Schirck’s Lab (http://www.schircks.com). In order to
isolate pteridine compounds chromatography was performed in the
same conditions as described above except using water as a mobile
phase.
2.5. Miscellaneous methods
ESI(+) mass spectrometry of pteridine compounds was performed
with Mariner (Perseptive Biosystem, USA) in the Korea Basic Science
Institute (Taejon, South Korea). SDS^PAGE analysis of proteins was
performed on denaturing conditions with a 12.5% polyacrylamide gel.
Protein was measured by the Bradford method using bovine serum
albumin as a standard.
3. Results
3.1. Identi¢cation of PPH4 synthesis by E. coli PTPS
A homology search of PTPS against the ¢nished genome
sequence of E. coli [22] revealed a putative protein encoded by
the unidenti¢ed gene ygcM. The translated protein consisted
of 121 amino acid residues which shared 26.3%, 27.8%, and
44.2% sequence identity with the respective PTPSs of human
(accession number JC1405), rat (A39499), and Synechocystis
sp. PCC 6803 (ORF slr0078) as shown in the multiple align-
ment (Fig. 1). Also conserved were most of the critical resi-
dues for catalysis, positioning the pterin ring, and coordinat-
ing with zinc ion (Fig. 1), which were originally suggested
from the crystal structure of rat PTPS [23]. In order to deter-
mine whether the putative E. coli gene encodes PTPS, the gene
was ampli¢ed by PCR from genomic DNA and cloned into
the pET-28a expression vector. The recombinant protein was
overexpressed, puri¢ed (Fig. 2B), and assayed for its activity
to synthesize PPH4 from H2-NTP. The assay was performed
in the absence or presence of mouse recombinant SR and
analyzed by HPLC after iodine oxidation. The enzymatic
products were eluted at the position corresponding to pterin
in the absence of SR (Fig. 2AII, upper) and biopterin in the
coupled assay with SR (Fig. 2AII, lower), supporting that the
enzymatic product of E. coli PTPS was PPH4. Therefore, it
was concluded that ygcM encodes a PTPS ortholog of E. coli.
The speci¢c activity was determined to be approx. 8.7% of the
human enzyme (Table 1).
3.2. Analysis of pteridine compounds produced by coexpression
transformants
We created an E. coli transformant carrying the coexpres-
sion plasmid, pET-cGTPCH/ePTPS, expecting that expression
Table 1
Comparative activity analysis of recombinant PTPSs
Organism Speci¢c activity (nmol/min/mg)
PTPS SSCR
E. coli 1.13T 0.04 99.36T 4.87
Synechocystis sp. PCC 6803 0.39T 0.01 97.67T 0.61
Drosophila 8.91T 0.20 0.34T 0.21
Human 13.03T 0.33 0.23T 0.01
The PTPS activity was measured by the synthesis of BH4 in the
coupled assay with SR. The SSCR activity was measured in the
standard assay conditions as described in Section 2. The mean val-
ues were determined from three independent experiments.
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of both cyanobacterial GTPCH and E. coli PTPS might gen-
erate high cellular concentrations of PPH4 and would in turn
cause some phenotypic change(s) in the transformant. In con-
trast to non-transformed cells which produce no pteridine
compounds in the medium, the transformant produced con-
siderable amounts of a pteridine compound (Figs. 2AIII and
3). However, the transformant exhibited no obvious growth
advantages under various stress conditions, such as UV light,
metal ions, ascorbate, and hydrogen peroxide (data not
shown). The pteridine compound in the medium was analyzed
by HPLC (Fig. 2AIII). Without iodine oxidation a small peak
appeared at the retention time corresponding to pterin (Fig.
2AIII, upper) but the peak increased several-fold after iodine
oxidation (Fig. 2AIII, lower). The peak fraction isolated from
the oxidized sample was further analyzed by mass spectrom-
etry to con¢rm the molecular mass of pterin (data not shown).
These data indicated that the transformant probably pro-
duced 7,8-dihydropterin a portion of which was oxidized to
pterin in the medium. Finally, the soluble fraction of the
sonicated transformant cells was analyzed by SDS^PAGE
(Fig. 2B) in order to identify overexpression of the recombi-
nant proteins. The recombinant GTPCH and PTPS were
clearly seen as dominant bands, which migrated at the same
rates as their puri¢ed counterparts shown in the parallel lanes.
It therefore was suggested that the recombinant Synechocystis
GTPCH and E. coli PTPS in the transformant contributed to
the production of 7,8-dihydropterin.
The above result did not resolve the question of whether the
7,8-dihydropterin originated from PPH4, which was expected
to occur by the recombinant proteins. In order to answer this
question, we created another E. coli transformant of pET-
cGTPCH/ePTPS/mSR, harboring an additional ORF for
mouse SR. We expected production of BH4 from the trans-
formant, if PPH4 were synthesized by E. coli PTPS. In con-
trast to our expectation, the transformant expressed barely
detectable amounts of mouse SR and thus did not produce
any form of biopterin but 7,8-dihydropterin (data not shown).
In the course of analyzing SR expression in the transformant
we found an enzymatic activity bleaching the yellow color of
sepiapterin in the absence of NADPH. The enzymatic product
analyzed by HPLC after iodine oxidation was pterin (see be-
low). As this activity has never been found in any enzymes, we
initially suspected the presence of a novel enzyme, which
might have been induced to cope with increased synthesis of
PPH4 in the transformant and also responsible for 7,8-dihy-
dropterin production from PPH4. In order to identify the
putative protein we performed puri¢cation of the protein
from the transformant using conventional chromatographies
and FPLC, but recombinant E. coli PTPS was what we ¢nally
puri¢ed to homogeneity (data not shown). The recombinant
enzyme puri¢ed previously by metal a⁄nity chromatography
was also con¢rmed to have the same activity. These results
strongly supported that E. coli PTPS is responsible for the
bleaching activity.
3.3. Identi¢cation of 7,8-dihydropterin catalyzed from
sepiapterin
The reaction mixture of sepiapterin with E. coli PTPS ex-
hibited £uorescence under UV light, indicating conversion of
sepiapterin to another pteridine compound. The time course
of the incubation analyzed by absorption spectra clearly
showed a gradual decrease of the sepiapterin peak at 420
nm with the concomitant increase of a new peak at 320 nm
(data not shown). Aliquots of the reaction mixture were also
Fig. 1. Multiple alignments of the amino acid sequences of PTPS proteins. Conserved sequences are shaded at four levels using GeneDoc soft-
ware and the residues suggested for catalysis (+), positioning of the pterin ring (!), and coordinating with zinc ion (*) are indicated.
Fig. 2. Identi¢cation of pteridines and recombinant proteins.
A: HPLC of the enzymatic products of E. coli PTPS and the pteri-
dine product of the cGTPCH/ePTPS transformant. AII: The puri-
¢ed recombinant E. coli PTPS was assayed using H2-NTP as a sub-
strate. After iodine oxidation, the enzymatic product was pterin in
the absence of SR (upper) or biopterin in the presence of SR (low-
er). AIII: The transformant medium was centrifuged to discard cell
precipitate and then injected for analysis before (upper) and after
(lower) iodine oxidation. AI: Standard pteridines were neopterin
(a), pterin (b), biopterin (c), and 6-hydroxymethylpterin (d). Pteri-
dines were separated on a C18 column isocratically with 10 mM so-
dium phosphate, pH 6.0, at a £ow rate of 1.2 ml/min. Fluorescence
was at 350/450 nm (em/ex). B: SDS^PAGE analysis of the recombi-
nant proteins in crude extract of the pET-cGTPCH/ePTPS trans-
formant. Lane 1, BL21; lane 2, transformant; lane 3, recombinant
Synechocystis GTPCH; lane 4, recombinant E. coli PTPS.
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analyzed by HPLC (Fig. 4). Direct injection of the reaction
mixtures exhibited a small £uorescent peak eluting at the po-
sition corresponding to pterin and increasing with incubation
times (Fig. 4A). When the same reaction mixtures were in-
jected after iodine oxidation, the pterin peak increased ap-
prox. 16-fold (Fig. 4B). These results suggested that the enzy-
matic product was the dihydro form of pterin. The pterin
peak isolated from the reaction mixture without iodine oxida-
tion was further analyzed by ESI(+) mass spectrometry to
show two major spectrum peaks corresponding to the molec-
ular masses of 163.1 and 165.1, which coincide exactly with
the respective values of pterin and 7,8-dihydropterin (data not
shown). Therefore, it was concluded that E. coli PTPS con-
verts sepiapterin to 7,8-dihydropterin, presumably cleaving
the C6 side chain of sepiapterin to yield 7,8-dihydropterin.
We tentatively named the activity sepiapterin side chain re-
leasing (SSCR) activity.
3.4. Enzymatic properties for SSCR activity
The optimum activity was found at pH 6.5^7.0 in 50 mM
Tris^HCl (Fig. 5A). The activity was inhibited 40^100% by
divalent metal ions (10 mM); the order of inhibition was
Mg2þ6Mn2þ6Ca2þ6Ni2þ6Zn2þ6Co2þ6Cu2þ. EDTA
stimulated the activity 110^120% at 1^5 mM but inhibited it
above 10 mM. The SSCR activity was increased 3.2-fold at
60^80‡C under the standard assay conditions (Fig. 5B). The
enzyme retained 76% of the activity after 10 min of incubation
at 80‡C, indicating high thermal stability of the protein (Fig.
5B). The Km value determined for sepiapterin was 0.92‡ T 0.18
mM and the Vmax was 151.3‡ T 15.8 nmol/min/mg (Table 2).
In order to examine whether SSCR activity is unique to
bacterial PTPS orthologs, the activity was determined in the
puri¢ed recombinant PTPSs of Synechocystis sp. PCC 6803,
Drosophila, and human, and compared with their activities for
PPH4 synthesis (Table 1). The cyanobacterial enzyme exhib-
ited high activity comparable to E. coli enzyme, while Droso-
phila and human enzymes showed barely detectable activities
corresponding to 0.34% and 0.23%, respectively, of the E. coli
enzyme. In contrast, the rates of PPH4 synthesis by bacterial
enzymes were less than 10% of the higher animal enzymes.
Fig. 3. Quantitative analysis of pterin production by the cGTPCH/
ePTPS transformant. Cell growth was measured at 600 nm (dashed
lines). Total pterin in the medium was measured by HPLC after io-
dine oxidation (solid line). The non-transformed BL21 is marked by
open circles and the transformant by closed circles. The non-trans-
formed cells did not produce pterin in measurable amounts.
Fig. 4. HPLC identi¢cation of the enzymatic product from sepia-
pterin. Sepiapterin was incubated with E. coli PTPS for the indi-
cated times and then subjected to HPLC before (A) and after (B)
iodine oxidation. C: A chromatogram of authentic pteridines, which
are also shown in Fig. 2. HPLC conditions are described in Fig. 2.
Table 2
Kinetic parameters of SSCR activity by E. coli PTPS
Km (mM) Vmax (nmol/min/mg) Turnover number (s31)
0.92T 0.18 151.3T 15.8 0.04
The kinetic parameters were determined in the standard assay con-
ditions using various concentrations of sepiapterin. The mean values
were determined from three independent experiments.
Fig. 5. E¡ects of pH and temperature on SSCR activity. A: SSCR
activity was measured in 0.05 M sodium phosphate (a ; pH
5.5^7.0), Tris^HCl (b ; pH 6.0^9.0), and glycine^NaOH (E ; pH
8.5^10.5). B: Temperature e¡ect on the activity (b) and enzyme
stability (a). Reactions were carried out at 37‡C in the standard as-
say conditions at the indicated temperatures. For thermal stability
analysis proteins were preincubated for 10 min at the indicated tem-
peratures and then assayed for the remaining activities in the stan-
dard conditions.
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4. Discussion
We demonstrated in vitro that the E. coli gene (ygcM) en-
codes a PTPS ortholog. Furthermore, the protein was veri¢ed
to have another new catalytic function to convert sepiapterin
to 7,8-dihydropterin (named SSCR activity). To our knowl-
edge, this activity has never been found in any enzymes in-
cluding PTPS, which has been studied extensively in mammals
as an essential enzyme for BH4 synthesis.
Sepiapterin has the chemical structure of 6-L-lactoyl-7,8-di-
hydropterin. Our result clearly showed that 7,8-dihydropterin
is one of the enzymatic products (Fig. 3). It therefore suggests
that SSCR activity may be accomplished through cleavage of
the C^C bond linking the lactoyl side chain at C6 of 7,8-
dihydropterin. Based on the proposed mechanism for PPH4
synthesis [23] and the conserved amino acid residues in E. coli
PTPS (Fig. 1), we speculate that a nucleophilic attack of res-
idue Cys27 occurs on C1P carbon of sepiapterin. The Cys27
residue in E. coli PTPS corresponds to rat Cys42, which was
suggested to abstract protons from the side chain C2P and C3P
carbons of H2-NTP for PPH4 synthesis. However, the de-
tailed catalysis remains unclear, because we did not succeed
in identifying the released side chain. A clear di¡erence be-
tween PTPS and SSCR activities by E. coli enzyme is that the
former required Mg2þ and reducing agents (data not shown),
while the latter did not. The role of Mg2þ and reducing agents
was also well established in higher animal enzymes [18,23^25].
The production of BH4 in a coupled assay of E. coli PTPS
with mouse SR (Fig. 1) provides unequivocal evidence that
E. coli PTPS catalyzes the synthesis of PPH4. However, it
remains a question whether the catalytic activity is exerted
in vivo, because the pET-cGTPCH/ePTPS transformant pro-
duced 7,8-dihydropterin (Fig. 3). It di¡ers from our previous
result that sepiapterin was a dominant product from the
transformant coexpressing cyanobacterial GTPCH with hu-
man PTPS [16]. It was suggested that the PPH4 synthesized
by human PTPS was converted to 6-LPH4 by endogenous
aldose reductase(s) in E. coli and then oxidized non-enzymati-
cally to sepiapterin [16]. In contrast to human PTPS, the
E. coli enzyme may not be competitive enough in vivo to
prevail over the dephosphorylation of H2-NTP, which is a
prerequisite for folate synthesis [26]. In addition, we found
that dihydroneopterin is converted to 7,8-dihydropterin by
E. coli PTPS; the speci¢c activity was determined to be 1.51
nmol/min/mg (data not shown), which corresponds to 1.55%
of the value for sepiapterin (Table 1). Therefore, it seems
plausible to postulate that H2-NTP might have been dephos-
phorylated to dihydroneopterin by non-speci¢c phospha-
tase(s) and then converted to 7,8-dihydropterin by SSCR ac-
tivity of E. coli PTPS. Of course, this suggestion does not
rationalize a physiological role of SSCR activity, because
none of the enzymatic substrates or products has a known
role in E. coli. Nevertheless, the above in vivo results may
be a clear demonstration that the E. coli PTPS ortholog has
a di¡erent physiological role from the human enzyme, prob-
ably signifying SSCR activity rather than PTPS activity in the
E. coli enzyme.
Synechocystis PTPS [13] was determined to have SSCR ac-
tivity comparable to the E. coli enzyme, while the Drosophila
and human enzymes showed negligible activities (Table 1).
This result suggests strongly that SSCR activity may be
more common and signi¢cant in bacterial PTPS orthologs,
which are found in a majority of prokaryotic genome sequen-
ces. The COGs (Clusters of Orthologous Groups of proteins)
website (http://www.ncbi.nlm.nih.gov/COG/) currently shows
33 bacterial PTPS orthologs assigned from 44 ¢nished micro-
bial genomes. This ubiquitous presence of putative PTPS or-
thologs in bacteria, which are devoid of SR and thus do not
produce BH4, may further imply a functional role of the
enzyme. If the E. coli PTPS ortholog does not exert PPH4
synthesis activity in vivo, SSCR activity may provide a clue
for understanding the presence of PTPS orthologs in bacteria.
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